Cargando…

Social and Financial Barriers to Optimum TKI Treatment in Patients with Chronic Myeloid Leukemia-A Knowledge-Attitudes-Practices Study from India

INTRODUCTION: Outcomes in chronic myeloid leukemia (CML) have vastly improved after introducing tyrosine kinase inhibitors. However, patients in low and middle-income countries (LMICs) face many challenges due to social and financial barriers. OBJECTIVE: This study was conducted to understand socio-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gupta, Naveen, Mahapatra, Manoranjan, Seth, Tulika, Tyagi, Seema, Sazawal, Sudha, Saxena, Renu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Università Cattolica del Sacro Cuore 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813279/ https://www.ncbi.nlm.nih.gov/pubmed/33489043 http://dx.doi.org/10.4084/MJHID.2021.004

Ejemplares similares

Chronic myeloid leukemia with a rare fusion transcript, b2a3 (e13a3) BCR–ABL1: A report of four cases from India
por: Sazawal, Sudha, et al.
Publicado: (2019)

Comparative analysis of the Sokal, Euro and European Treatment and Outcome Study score in prognostication of Indian chronic myeloid leukemia-chronic phase patients on imatinib
por: Chhikara, Sunita, et al.
Publicado: (2018)

Report of chronic myeloid leukemia in chronic phase from All India Institute of Medical Sciences, 1990-2010
por: Mishra, Pravas, et al.
Publicado: (2013)

Study of Bone Marrow Lymphocyte Subset in Acute Myeloid Leukemia
por: Dange, Prasad, et al.
Publicado: (2021)

Cytogenetics’ impact on the prognosis of acute myeloid leukemia
por: Gupta, Monika, et al.
Publicado: (2019)

Cytogenetic profile of Indian patients with de novo myelodysplastic syndromes
por: Chaubey, Rekha, et al.
Publicado: (2011)

Hairy cell leukemia: A decade long experience of North Indian Hematology Center
por: Somasundaram, Venkatesan, et al.
Publicado: (2014)

Trisomy Chromosome 6 as a Sole Cytogenetic Abnormality in Acute Myeloid Leukemia
por: Gupta, Monika, et al.
Publicado: (2015)

Influence of JAK2V617F allele burden on clinical phenotype of polycythemia vera patients: A study from India
por: Sazawal, Sudha, et al.
Publicado: (2019)

Prevalence and Impact of HMOX1 Polymorphism (rs2071746: A > T) in Indian Sickle Cell Disease Patients
por: Pandey, Hareram, et al.
Publicado: (2023)

Current state of non-hematologic cancer-associated thrombosis at a tertiary care hospital in India
por: Aggarwal, Mukul, et al.
Publicado: (2023)

Aberrant myeloid antigen co-expression is correlated with high percentages of CD34-positive cells among blasts of acute lymphoblastic leukemia patients: an Indian tertiary care center perspective
por: Sharma, Rahul Kumar, et al.
Publicado: (2014)

Immunophenotypic Profile of Multiple Myeloma: A Tertiary Care Centre Experience
por: Rath, Asish, et al.
Publicado: (2023)

Molecular Response to Imatinib and Its Correlation with mRNA Expression Levels of Imatinib Influx Transporter (OCT1) in Indian Chronic Myeloid Leukemia Patients
por: Chhikara, S, et al.
Publicado: (2017)

Clinical Profile of Patients with Rare Inherited Coagulation Disorders: A Retrospective Analysis of 67 Patients from Northern India
por: Sharma, Sanjeev Kumar, et al.
Publicado: (2012)

Mild Bleeders: Diagnosis is Elusive in Large Number of Patients
por: Kotru, Mrinalini, et al.
Publicado: (2016)

Value of CD16/CD66b/CD45 in comparison to CD55/CD59/CD45 in diagnosis of paroxysmal nocturnal haemoglobinuria: An Indian experience
por: Kotru, Mrinalini, et al.
Publicado: (2017)

The TKI Era in Chronic Leukemias
por: De Novellis, Danilo, et al.
Publicado: (2021)

Monitoring the Response to Tyrosine Kinase Inhibitor (TKI) Treatment in Chronic Myeloid Leukemia (CML)
por: Haznedaroglu, Ibrahim C.
Publicado: (2014)

Syndecan-1 (sCD138) levels in chronic lymphocytic leukemia: clinical and hematological correlations
por: Sharma, Monica, et al.
Publicado: (2018)

Polymorphism T81C in H-RAS Oncogene Is Associated With Disease Progression in Imatinib (TKI) Treated Chronic Myeloid Leukemia Patients
por: Mir, Rashid, et al.
Publicado: (2015)

An unusual clonal cytogenetic abnormality with t(15;17)(p11;q21) in a patient with severe aplastic anemia
por: Sharma, Sanjeev K., et al.
Publicado: (2012)

A review of the therapeutic role of the new third-generation TKI olverembatinib in chronic myeloid leukemia
por: Qian, Honglan, et al.
Publicado: (2022)

Unusual massive bone marrow fibrosis in acute promyelocytic leukemia following arsenic trioxide therapy
por: Venkatesan, S., et al.
Publicado: (2015)

An observational study on risk of secondary cancers in chronic myeloid leukemia patients in the TKI era in the United States
por: Kumar, Vivek, et al.
Publicado: (2018)

Targeting BCR-ABL-Independent TKI Resistance in Chronic Myeloid Leukemia by mTOR and Autophagy Inhibition
por: Mitchell, Rebecca, et al.
Publicado: (2017)

Comprehensive analysis of the immune pattern of T cell subsets in chronic myeloid leukemia before and after TKI treatment
por: Yao, Danlin, et al.
Publicado: (2023)

Importance of TKI treatment duration in treatment-free remission of chronic myeloid leukemia: results of the D-FREE study
por: Yoshida, Chikashi, et al.
Publicado: (2023)

Optimization and Identification of Single Mutation in Hemoglobin Variants with 2,2,2 Trifluoroethanol Modified Digestion Method and Nano−LC Coupled MALDI MS/MS
por: Dasauni, Pushpanjali, et al.
Publicado: (2022)

JAK2 mutation in patients with splanchnic venous thrombosis: A pilot study from India
por: Sazawal, S., et al.
Publicado: (2012)

Prospective monitoring of chronic myeloid leukemia patients from the time of TKI discontinuation: the fate of peripheral blood CD26(+) leukemia stem cells
por: Pacelli, Paola, et al.
Publicado: (2023)

Exercise-induced release of cardiac and skeletal muscle injury biomarkers in patients with chronic myeloid leukemia receiving TKI therapy
por: Janssen, Lando, et al.
Publicado: (2023)

Diamond Blackfan Anemia: a Tertiary Care Center Experience
por: Singh, Avinash Kumar, et al.
Publicado: (2013)

TKI-Related Platelet Dysfunction Does Not Correlate With Bleeding in Patients With Chronic Phase-Chronic Myeloid Leukemia With Complete Hematological Response
por: Sener, Yigit, et al.
Publicado: (2019)

Quality‐of‐life, mental health, and perspective on TKI dose reduction as a prelude to discontinuation in chronic phase chronic myeloid leukemia
por: Chen, Yilin, et al.
Publicado: (2023)

Diagnostic and Treatment Obstacles in Acute Myeloid Leukemia: Social, Operational, and Financial
por: Genç, Emine Eylem, et al.
Publicado: (2023)

Transfusion practices during the COVID-19 pandemic: An experience from a hematology daycare in India
por: Senapati, Jayastu, et al.
Publicado: (2021)

Antithrombin III Deficiency in Indian Patients with Deep Vein Thrombosis: Identification of First India Based AT Variants Including a Novel Point Mutation (T280A) that Leads to Aggregation
por: Bhakuni, Teena, et al.
Publicado: (2015)

Clinical Profile of Dengue Infection in Patients with Hematological Diseases
por: Sharma, Sanjeev Kumar, et al.
Publicado: (2011)

The BIM deletion polymorphism: A paradigm of a permissive interaction between germline and acquired TKI resistance factors in chronic myeloid leukemia
por: Ko, Tun Kiat, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_t9q87tcrn9nc6fnv2pcmji07qu